Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(2.09)
# 1,673
Out of 4,479 analysts
222
Total ratings
29.91%
Success rate
-2.26%
Average return
Main Sectors:
Top Industries:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $18.06 | +315.28% | 16 | Jun 27, 2024 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $400 | $247.61 | +61.54% | 17 | Jun 24, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $90 | $25.22 | +256.86% | 12 | Jun 11, 2024 | |
| LBPH Longboard Pharmaceuticals | Reiterates: Buy | $60 | $30.74 | +95.19% | 10 | Jun 11, 2024 | |
| VIR Vir Biotechnology | Reiterates: Buy | $110 | $8.85 | +1,142.94% | 16 | Jun 5, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $34.80 | +187.36% | 13 | Jun 5, 2024 | |
| MIST Milestone Pharmaceuticals | Reiterates: Buy | $25 | $1.35 | +1,751.85% | 11 | May 30, 2024 | |
| DTIL Precision BioSciences | Reiterates: Buy | $60 | $9.41 | +537.62% | 12 | May 30, 2024 | |
| IVVD Invivyd | Reiterates: Buy | $15 | $1.10 | +1,263.64% | 9 | May 24, 2024 | |
| MNMD Mind Medicine (MindMed) | Reiterates: Buy | $35 | $6.96 | +402.87% | 13 | May 24, 2024 | |
| GOSS Gossamer Bio | Reiterates: Buy | $10 | $0.96 | +941.88% | 8 | May 20, 2024 | |
| ATAI Atai Life Sciences | Reiterates: Buy | $15 | $1.30 | +1,053.85% | 11 | May 17, 2024 | |
| VYGR Voyager Therapeutics | Reiterates: Buy | $30 | $7.59 | +295.26% | 2 | May 16, 2024 | |
| CYBN Cybin | Reiterates: Buy | $5 | $0.26 | +1,787.50% | 11 | May 16, 2024 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $5 | $0.32 | +1,462.01% | 11 | May 15, 2024 | |
| ONCY Oncolytics Biotech | Reiterates: Buy | $5 | $0.99 | +405.05% | 12 | May 14, 2024 | |
| ALT Altimmune | Reiterates: Buy | $12 | $6.74 | +78.04% | 10 | May 14, 2024 | |
| CMPS COMPASS Pathways | Reiterates: Buy | $120 | $5.96 | +1,913.42% | 8 | May 13, 2024 | |
| QURE uniQure | Reiterates: Buy | $25 | $4.01 | +523.44% | 7 | May 8, 2024 | |
| GHRS GH Research | Reiterates: Buy | $40 | $11.91 | +235.85% | 8 | May 7, 2024 | |
| BNTC Benitec Biopharma | Maintains: Buy | $170 → $68 | $8.70 | +681.61% | 2 | Sep 23, 2022 | |
| ALLK Allakos | Maintains: Buy | $230 → $20 | $0.84 | +2,279.25% | 2 | Dec 28, 2021 | |
| MNDY monday.com | Maintains: Outperform | n/a | $237.03 | - | 1 | Aug 18, 2021 |
Silence Therapeutics
Jun 27, 2024
Reiterates: Buy
Price Target: $75
Current: $18.06
Upside: +315.28%
Alnylam Pharmaceuticals
Jun 24, 2024
Reiterates: Buy
Price Target: $400
Current: $247.61
Upside: +61.54%
Arrowhead Pharmaceuticals
Jun 11, 2024
Reiterates: Buy
Price Target: $90
Current: $25.22
Upside: +256.86%
Longboard Pharmaceuticals
Jun 11, 2024
Reiterates: Buy
Price Target: $60
Current: $30.74
Upside: +95.19%
Vir Biotechnology
Jun 5, 2024
Reiterates: Buy
Price Target: $110
Current: $8.85
Upside: +1,142.94%
Immunocore Holdings
Jun 5, 2024
Reiterates: Buy
Price Target: $100
Current: $34.80
Upside: +187.36%
Milestone Pharmaceuticals
May 30, 2024
Reiterates: Buy
Price Target: $25
Current: $1.35
Upside: +1,751.85%
Precision BioSciences
May 30, 2024
Reiterates: Buy
Price Target: $60
Current: $9.41
Upside: +537.62%
Invivyd
May 24, 2024
Reiterates: Buy
Price Target: $15
Current: $1.10
Upside: +1,263.64%
Mind Medicine (MindMed)
May 24, 2024
Reiterates: Buy
Price Target: $35
Current: $6.96
Upside: +402.87%
Gossamer Bio
May 20, 2024
Reiterates: Buy
Price Target: $10
Current: $0.96
Upside: +941.88%
Atai Life Sciences
May 17, 2024
Reiterates: Buy
Price Target: $15
Current: $1.30
Upside: +1,053.85%
Voyager Therapeutics
May 16, 2024
Reiterates: Buy
Price Target: $30
Current: $7.59
Upside: +295.26%
Cybin
May 16, 2024
Reiterates: Buy
Price Target: $5
Current: $0.26
Upside: +1,787.50%
Sangamo Therapeutics
May 15, 2024
Reiterates: Buy
Price Target: $5
Current: $0.32
Upside: +1,462.01%
Oncolytics Biotech
May 14, 2024
Reiterates: Buy
Price Target: $5
Current: $0.99
Upside: +405.05%
Altimmune
May 14, 2024
Reiterates: Buy
Price Target: $12
Current: $6.74
Upside: +78.04%
COMPASS Pathways
May 13, 2024
Reiterates: Buy
Price Target: $120
Current: $5.96
Upside: +1,913.42%
uniQure
May 8, 2024
Reiterates: Buy
Price Target: $25
Current: $4.01
Upside: +523.44%
GH Research
May 7, 2024
Reiterates: Buy
Price Target: $40
Current: $11.91
Upside: +235.85%
Benitec Biopharma
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $8.70
Upside: +681.61%
Allakos
Dec 28, 2021
Maintains: Buy
Price Target: $230 → $20
Current: $0.84
Upside: +2,279.25%
monday.com
Aug 18, 2021
Maintains: Outperform
Price Target: n/a
Current: $237.03
Upside: -